充血性心力衰竭中的基质金属蛋白酶-9和金属蛋白酶组织抑制剂-1 - Suppr | 超能文献

Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in congestive heart failure.

作者信息

Gerlach Raquel F, Tanus-Santos Jose E

出版信息

Am Heart J. 2006 Jul;152(1):e9. doi: 10.1016/j.ahj.2006.04.022.

DOI:10.1016/j.ahj.2006.04.022

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in congestive heart failure.充血性心力衰竭中的基质金属蛋白酶-9和金属蛋白酶组织抑制剂-1

Am Heart J. 2006 Jul;152(1):e9. doi: 10.1016/j.ahj.2006.04.022.

2

Tissue inhibitor of metalloproteinases levels in patients with chronic heart failure: an independent predictor of mortality.慢性心力衰竭患者金属蛋白酶组织抑制剂水平：死亡率的独立预测指标

Eur J Heart Fail. 2008 Apr;10(4):388-95. doi: 10.1016/j.ejheart.2008.02.015. Epub 2008 Mar 17.

3

[Involvement of matrix metalloproteinases in the regulation of myocardial extracellular matrix in patients with congestive heart failure].[基质金属蛋白酶在充血性心力衰竭患者心肌细胞外基质调节中的作用]

Zhonghua Yi Xue Za Zhi. 2006 Jun 27;86(24):1693-6.

4

Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis.基质金属蛋白酶-9和基质金属蛋白酶-2作为多发性硬化症不同病程的生物标志物。

Mult Scler. 2009 Mar;15(3):316-22. doi: 10.1177/1352458508099482. Epub 2009 Jan 19.

5

A strong note of caution in using matrix metalloproteinase-1 and its inhibitor, TIMP-1 in serum as biomarkers in systolic heart failure.在将血清中的基质金属蛋白酶-1及其抑制剂TIMP-1用作收缩性心力衰竭的生物标志物时需格外谨慎。

J Intern Med. 2008 Sep;264(3):291-3. doi: 10.1111/j.1365-2796.2008.01952.x. Epub 2008 Mar 13.

6

Matrix metalloproteinase-1 and its inhibitor, TIMP-1, in systolic heart failure: relation to functional data and prognosis.基质金属蛋白酶-1及其抑制剂TIMP-1在收缩性心力衰竭中的作用：与功能数据及预后的关系

J Intern Med. 2007 Sep;262(3):385-92. doi: 10.1111/j.1365-2796.2007.01823.x.

7

Matrix metalloproteinase-2, -9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension.高血压患者体内的基质金属蛋白酶-2、-9及金属蛋白酶组织抑制剂-1

Endothelium. 2006 May-Jun;13(3):227-31. doi: 10.1080/10623320600780942.

8

Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.肥厚型心肌病中的基质金属蛋白酶与组织重塑

Am Heart J. 2008 Jul;156(1):85-91. doi: 10.1016/j.ahj.2008.01.035.

9

Matrix metalloproteinases-2, -9 and tissue inhibitor of metallo-proteinase-1 in lung cancer invasion and metastasis.

Chin Med J (Engl). 2005 Jan 5;118(1):69-72.

10

Variations with time of plasma concentrations of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2.基质金属蛋白酶2和9以及金属蛋白酶组织抑制剂1和2的血浆浓度随时间的变化

Thromb Res. 2007;119(2):261-3. doi: 10.1016/j.thromres.2006.01.018. Epub 2006 Mar 13.

引用本文的文献

1

Plasma tissue inhibitor of matrix metalloproteinase-1 (TIMP-1): an independent predictor of poor response to cardiac resynchronization therapy.血浆组织基质金属蛋白酶抑制剂-1（TIMP-1）：心脏再同步治疗反应不良的独立预测因子。

Eur J Heart Fail. 2010 May;12(5):492-8. doi: 10.1093/eurjhf/hfq037. Epub 2010 Apr 1.